• Home
• About Us
  • Our Mission
  • History
  • Corporate Structure
  • Key Financial data
    • Key Data
    • Net Sales
    • Sales by Business
    • Pharmaceuticals: Net Sales
    • Key P&L and EBITDA
    • Balance Sheet Structure
    • Per Share Data
  • Management
  • Contacts
• Pharmaceutical Operations
  • Markets
    • Specialty and Primary Care
    • Rare Diseases
  • Products
    • Specialty and Primary Care Products
    • Rare Diseases Products
  • R & D
    • Pipeline
    • Pubblications
  • Pharmaceutical Production
  • Pharmaceutical Chemicals
    • Products
    • Production
    • D.M.F. & C.E.P.
• Rare Diseases
• Investors
  • Recordati at a glance
  • Recordati Share
  • Key Financial data
    • Key data
    • Net Sales
    • Sales by Business
    • Pharmaceuticals: Net Sales
    • Key P&L and EBITDA
    • Balance Sheet Structure
    • Per Share Data
  • News & Announcements
    • Business & financial news
    • Other press releases
    • Announcements
  • Public Tender Offer
  • Company Presentations
  • Annual & Interim Reports
  • Regulated Information Service Providers
  • Shareholders' Meetings
    • Reverse Merger into Recordati S.p.A. 2020/2021
    • Regulations for Shareholders' Meetings
  • Calendar
  • Analyst Coverage
  • Contacts IR
  • Internal Dealing
    • Internal Dealing Regulations
    • Internal Dealing Press Releases
• Sustainability
  • Sustainability strategy
    • Group’s Stakeholders
    • Materiality Analysis
    • Sustainability Plan
    • Sustainability governance
  • Business ethics & integrity
    • The Organisational, Management and Control Model
    • Internal Audit and Risk Management System
  • People's health: Recordati's priority since the beginning
    • Research & Development
    • Access to medicine and healthcare
    • Product quality and safety
    • Responsible marketing
  • The Recordati group’s employees
    • The importance of our employees
    • Diversity and equal opportunities
    • Remuneration and benefit system
    • Training and development of human capital
    • Health and safety
    • Industrial relations
  • Focus on the environment
    • Commitment to environmental protection
    • Energy use
    • Principal initiatives to combat climate change
    • Water management
    • Waste management
  • Suppliers and strategic partners
    • Supply-chain profile and responsible sourcing
  • Support for local communities
    • Donations
  • Initiatives in the context of the COVID-19 emergency
  • Documents
  • Contact
• Corporate Governance
  • Company by Laws
  • Board of Directors
  • Board of Statutory Auditors
  • Firm of Auditors
  • Shareholders agreements
    • In force
    • Historical Record
  • Report on Corporate Governance and the Ownership Structure
  • Remuneration
    • Remuneration Reports
    • Stock Option Plans
  • Share Buy-back
  • Related Parties
    • Regulations for Related-Party Transactions
  • Compliance programmes
  • Changes in share capital
  • Other Corporate Documents
  • Corporate Affairs Contacts
  • Relevant Information and Inside Information
• News & Announcements
  • Business & financial news
  • Other press releases
  • Announcements
• Partnering
  • Our Capabilities
  • Our Needs
  • Contacts
  • Selected Partnerships
• Join Us
  • Training for further development
  • Internships: start building Your future
  • Professional Areas
• International Presence

Menu

• Recordati at a glance
• Recordati Share
• Key Financial data
  • Key data
  • Net Sales
  • Sales by Business
  • Pharmaceuticals: Net Sales
  • Key P&L and EBITDA
  • Balance Sheet Structure
  • Per Share Data
• News & Announcements
  • Business & financial news
  • Other press releases
  • Announcements
• Public Tender Offer
• Company Presentations
• Annual & Interim Reports
• Regulated Information Service Providers
• Shareholders' Meetings
  • Reverse Merger into Recordati S.p.A. 2020/2021
  • Regulations for Shareholders' Meetings
• Calendar
• Analyst Coverage
• Contacts IR
• Internal Dealing
  • Internal Dealing Regulations
  • Internal Dealing Press Releases

InvestorsKey Financial dataSales by Business